Steven Denbaars, Director at Akoustis Technologies, Inc. (AKTS), sold 7,000 shares at $8.08 ($57K) on 2021-10-11, disclosed to the SEC on 2021-10-13.
Open-market sale of $57k AKTS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| PrivatePalomino Laboratories Inc. | BUY | 2026-04-20 | $50K | — | Filing → |
| ALMU | SELL | 2026-02-27 | $418K | — | Filing → |
| ALMU | BUY | 2025-05-23 | $100K | — | Filing → |